UCB News and Activities

Presence

UCB develops and sells medicines for severe diseases, with a focus on neurology and immunology. Its products and services support patients, hospitals, and healthcare professionals worldwide.

UCB products and services overview:

  • Neurology medicines
  • Immunology medicines
  • Rare disease treatments
  • Biologic therapies

Revenue: ~$7 billion

Employees: 9,000

Headquarters: Brussels, Belgium


UCB is one of the...

UCB is a company listed under the stock ticker UCB (BE).

UCB has a direct presence in 9 countries.

UCB has 9 subsidiaries including UCB Australia, UCB Canada and UCB France.

They are in:

Acquisition, funding and merger involving UCB.

Executives

View the org chart displaying its 86 main executives

Most searched biographies at UCB

Create your alert
to follow the executive moves at UCB.

Pharmaceuticals

UCB has 1,916 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals
Popular contacts in Pharmaceuticals

Learn more about the Pharmaceuticals industry

News

Press releases by UCB
Social media about UCB

Get in Touch

Call UCB at +32 ...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board